Some of the interesting stories researchers were discussing at this year’s American Society of Microbiology meeting in San Francisco.
News & Opinion
Covering the life sciences inside and out
Most Recent
An Amgen executive refutes accusations that the company published misleading results of its mid-90s clinical trial testing an anemia drug.
New computational modeling suggests pre-existing HIV drug resistance mutations may contribute more to drug failure than previously thought.
African justice systems must change to help curb HIV and tuberculosis transmission in prisons.
Engaging the brain with cognitive tasks helps paralyzed rats walk again.
A growth factor isolated from human stem cells shows promising results in a mouse model of multiple sclerosis.
What researchers are learning as they sequence, map, and decode species’ genomes
Amgen’s incomplete report on an early major trial of epoetin misled the medical community about the anemia drug’s risks and benefits—and helped make Amgen rich.
Researchers identify two new DNA repair systems, in addition to four that were already known, that can attack unprotected telomeres.
Editors at PLoS Medicine suggest that merely disclosing conflicts of interest is insufficient and possibly even counterproductive.
Subjects
- cancer
- cell & molecular biology
- culture
- disease/medicine
- ecology
- evolution
- genetics & genomics
- neuroscience
- opinion
- techniques
Sub Categories
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
